M. Durante

Drug and disease signature integration identifies synergistic combinations in glioblastoma

Nicholas J. Lyons, Michael A. Durante, T. Golub, 2018, Nature Communications.

Punctuated evolution of canonical genomic aberrations in uveal melanoma

Michael A. Durante, A. Bowcock, J. Harbour, 2018, Nature Communications.

Single-cell analysis reveals new evolutionary complexity in uveal melanoma

Michael A. Durante, J. Harbour, S. Kurtenbach, 2020, Nature Communications.

Synthetic Lethal Screen to Identify Molecular Mechanisms that Drive Uveal Melanoma

Michael A. Durante, J. Licht, A. Riva, 2019 .

Fate of developmental mechanisms of myocardial plasticity in the postnatal heart

Michael A. Durante, J. Harbour, K. Hatzistergos, 2019, bioRxiv.